|
KMID : 1161420160190080789
|
|
Journal of Medicinal Food
2016 Volume.19 No. 8 p.789 ~ p.797
|
|
|
Beneficial Effects of Silymarin After the Discontinuation of CCl4-Induced Liver Fibrosis
|
|
Clichici Simona
Olteanu Diana
Filip Adriana
Nagy Andras-Laszlo
Oros Adrian
Mircea Petru A.
|
|
|
Abstract
|
|
|
|
Silymarin (Si) is a herbal product with hepatoprotective potential, well-known for its antioxidant, anti-inflammatory, and immunomodulatory properties. We have recently demonstrated that the usual therapeutic doses of Si are capable of inhibiting the progression of incipient liver fibrosis. We aimed at further investigating the benefits of Si administration upon liver alterations after the hepatotoxin discontinuation, using CCl4 to induce liver injuries on rats. CCl4 administration induces first of all oxidative stress, but other mechanisms, such as inflammation and liver fibrosis are also triggered. Fifty Wistar rats were randomly divided into five groups (n?=?10). The control group received sunflower oil twice a week for 8 weeks. Carboxymethyl cellulose group received sunflower oil twice a week, for 8 weeks and CMC daily, for the next 2 weeks. CCl4 group received CCl4 in sunflower oil, by gavage, twice a week, for 8 weeks. CCl4?+?Si 50 group received CCl4 twice a week, for 8 weeks, and then 50?mg/body weight (b.w.) Silymarin for the next 2 weeks. CCl4?+?Si 200 group was similar to the previous group, but with Si 200?mg/b.w. Ten weeks after the experiment had begun, we assessed inflammation (IL-6, MAPK, NF-κB, pNF-κB), fibrosis (hyaluronic acid), TGF-β1, MMP-9, markers of hepatic stellate cell activation (α-SMA expression), and proliferative capacity (proliferating cell nuclear antigen). Our data showed that Silymarin administered after the toxic liver injury is capable of reducing inflammation and liver fibrosis. The benefits were more important for the higher dose than for the usual therapeutic dose.
|
|
|
KEYWORD
|
|
|
anti-inflammatory, antioxidant, hepatic toxicity, liver fibrosis, NF-κB
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
 
|
|